These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15184706)

  • 1. Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.
    Russo S; Boon JC; Kema IP; Willemse PH; den Boer JA; Korf J; de Vries EG
    Psychosom Med; 2004; 66(3):422-5. PubMed ID: 15184706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.
    Kema IP; Meijer WG; Meiborg G; Ooms B; Willemse PH; de Vries EG
    Clin Chem; 2001 Oct; 47(10):1811-20. PubMed ID: 11568091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
    Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
    Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma tryptophan in carcinoid patients is associated with increased urinary cortisol excretion.
    Tanke MA; Kema IP; Dijck-Brouwer J; Doornbos B; De Vries EG; Korf J
    Psychoneuroendocrinology; 2008 Oct; 33(9):1297-301. PubMed ID: 18722719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor.
    Spigset O; Kristoffersson A; Mjörndal T
    Scand J Clin Lab Invest; 2004; 64(1):3-8. PubMed ID: 15025423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
    Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
    Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.
    Coccaro EF; Lee R; Kavoussi RJ
    J Psychiatr Res; 2010 Feb; 44(3):137-42. PubMed ID: 19767013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.
    Meijer WG; Kema IP; Volmer M; Willemse PH; de Vries EG
    Clin Chem; 2000 Oct; 46(10):1588-96. PubMed ID: 11017936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
    Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
    Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
    Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients.
    Gelegen V; Tamam L
    Compr Psychiatry; 2018 May; 83():64-70. PubMed ID: 29604524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone and prolactin secretion in the carcinoid syndrome.
    Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S
    Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatographic profiling of tryptophan and related indoles in body fluids and tissues of carcinoid patients.
    Kema IP; Schellings AM; Hoppenbrouwers CJ; Rutgers HM; de Vries EG; Muskiet FA
    Clin Chim Acta; 1993 Nov; 221(1-2):143-58. PubMed ID: 7512001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers.
    McCloskey MS; Ben-Zeev D; Lee R; Berman ME; Coccaro EF
    Psychopharmacology (Berl); 2009 Mar; 203(1):53-61. PubMed ID: 18946662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of central serotonin affects emotional information processing in impulsive aggressive personality disorder.
    Lee RJ; Gill A; Chen B; McCloskey M; Coccaro EF
    J Clin Psychopharmacol; 2012 Jun; 32(3):329-35. PubMed ID: 22544009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
    van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
    Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical investigation of carcinoid tumors].
    Dreux C; Bousquet B; Halter D
    Ann Biol Clin (Paris); 1973; 31(4):283-94. PubMed ID: 4723409
    [No Abstract]   [Full Text] [Related]  

  • 20. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.